Currently, the state-of-the-art for this purpose is performing Fc backbone mutation to fully abolish Fc–FcγR interactions [55,62] so that the risk of ADE is abrogated, along with other effector functions. This evidence concerns the gene FCGR2A and acute disseminated encephalomyelitis.